| scholarly article | Q13442814 |
| P356 | DOI | 10.1148/RADIOL.2211001624 |
| P698 | PubMed publication ID | 11568334 |
| P50 | author | Luigi Solbiati | Q56761009 |
| P2093 | author name string | Goldberg SN | |
| Cova L | |||
| Gazelle GS | |||
| Livraghi T | |||
| Meloni F | |||
| Halpern EF | |||
| Ierace T | |||
| Dellanoce M | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | colorectal carcinoma | Q25493920 |
| colorectal cancer | Q188874 | ||
| P304 | page(s) | 159-166 | |
| P577 | publication date | 2001-10-01 | |
| P1433 | published in | Radiology | Q3285690 |
| P1476 | title | Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients | |
| P478 | volume | 221 |
| Q30367068 | 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer |
| Q37231725 | A comparative experimental study of the in-vitro efficiency of hypertonic saline-enhanced hepatic bipolar and monopolar radiofrequency ablation |
| Q36063431 | A cost-utility analysis of treatments for malignant liver tumours: a pilot project |
| Q26770019 | Ablation techniques for primary and metastatic liver tumors |
| Q57114629 | Accuracy assessment of a potential clinical use of navigation-guided intra-operative liver metastasis brachytherapy-a planning study |
| Q33866394 | Activation and dramatically increased cytolytic activity of tumor specific T lymphocytes after radio-frequency ablation in patients with hepatocellular carcinoma and colorectal liver metastases |
| Q36789123 | Actual role of radiofrequency ablation of liver metastases |
| Q33795173 | Adaptive management of liver cancer radiotherapy |
| Q57338183 | Aktueller Stand der Radiofrequenzablation von Lebertumoren |
| Q42810563 | Analysis and experimental validation of a triaxial antenna for microwave tumor ablation |
| Q37223136 | Angled Cool-Tip Electrode for Radiofrequency Ablation of Small Superficial Subcapsular Tumors in the Liver: A Feasibility Study |
| Q42631253 | Bipolar radiofrequency ablation in ex vivo bovine liver with the open-perfused system versus the cooled-wet system |
| Q30872798 | Breast cancer liver metastases: US-guided percutaneous radiofrequency ablation--intermediate and long-term survival rates |
| Q39656970 | CD95 is a key mediator of invasion and accelerated outgrowth of mouse colorectal liver metastases following radiofrequency ablation |
| Q35059732 | CT-guided radiofrequency ablation as a salvage treatment of colorectal cancer hepatic metastases developing after hepatectomy. |
| Q53654118 | CT-guided radiofrequency ablation of a bronchogenic carcinoma |
| Q40477625 | Characterization of the RF ablation-induced 'oven effect': the importance of background tissue thermal conductivity on tissue heating. |
| Q34873168 | Chemotherapy plus percutaneous radiofrequency ablation in patients with inoperable colorectal liver metastases |
| Q35233514 | Clinical applications of radio-frequency ablation in liver metastasis of colorectal cancer |
| Q38285540 | Clinical trials of interventional oncology-moving from efficacy to outcomes |
| Q38787064 | Colorectal Cancer Liver Metastases: Biopsy of the Ablation Zone and Margins Can Be Used to Predict Oncologic Outcome |
| Q26778009 | Colorectal cancer: Metastases to a single organ |
| Q36582275 | Colorectal liver metastases: regional chemotherapy via transarterial chemoembolization (TACE) and hepatic chemoperfusion: an update |
| Q41592625 | Combined CT-guided radiofrequency ablation with systemic chemotherapy improves the survival for nasopharyngeal carcinoma with oligometastasis in liver: Propensity score matching analysis |
| Q47602818 | Combined hepatic and inferior vena cava resection for colorectal metastases |
| Q55020702 | Combined magnetic resonance imaging and optical surgical navigation system guidance of percutaneous liver cryoablation in a porcine model. |
| Q35005564 | Combining partial liver resection and local ablation of liver tumours: a preliminary Dutch experience |
| Q35574968 | Comparison of tissue pressure and ablation time between the LeVeen and cool-tip needle methods |
| Q37231971 | Comparison of wet radiofrequency ablation with dry radiofrequency ablation and radiofrequency ablation using hypertonic saline preinjection: ex vivo bovine liver |
| Q35123029 | Complication, local recurrence, and survival rates after radiofrequency ablation for hepatic malignancies |
| Q38232561 | Complications of image-guided thermal ablation of liver and kidney neoplasms |
| Q37789649 | Computed tomography (CT)-guided versus laparoscopic radiofrequency ablation: a single-institution comparison of morbidity rates and hospital costs |
| Q35376725 | Computer planned, image-guided combined resection and ablation for bilobar colorectal liver metastases |
| Q79387628 | Curative in situ ablation of colorectal liver metastases-experimental and clinical implementation |
| Q82606652 | Curative stereotactic body radiotherapy for liver malignancy |
| Q36828555 | Current oncologic applications of radiofrequency ablation therapies |
| Q90342567 | Cytoreduction for colorectal metastases: liver, lung, peritoneum, lymph nodes, bone, brain. When does it palliate, prolong survival, and potentially cure? |
| Q50247451 | Design and ex vivo kidney evaluation of a high-intensity focused ultrasound transducer and 3D positioner |
| Q27014926 | Development of a research agenda for the management of metastatic colorectal cancer: proceedings from a multidisciplinary research consensus panel |
| Q34321360 | Do Liposomal Apoptotic Enhancers Increase Tumor Coagulation and End-Point Survival in Percutaneous Radiofrequency Ablation of Tumors in a Rat Tumor Model? |
| Q36555907 | Dosimetric parameter predicting the deterioration of hepatic function after helical tomotherapy in patients with unresectable locally advanced hepatocellular carcinoma |
| Q41934918 | Evaluation of YO-PRO-1 as an early marker of apoptosis following radiofrequency ablation of colon cancer liver metastases |
| Q35010404 | Factors for early tumor recurrence of single small hepatocellular carcinoma after percutaneous radiofrequency ablation therapy |
| Q40558870 | Fiber-optic chirped FBG for distributed thermal monitoring of ex-vivo radiofrequency ablation of liver |
| Q43500810 | First and repeat resection of colorectal liver metastases in elderly patients |
| Q46011640 | Five-year survival in 309 patients with colorectal liver metastases treated with radiofrequency ablation. |
| Q42150472 | Guidelines for resection of colorectal cancer liver metastases. |
| Q89908197 | Hepatic Arterial Infusion Oxaliplatin Plus Oral S-1 Chemotherapy in Gastric Cancer with Unresectable Liver Metastases: A Case Series and Literature Review |
| Q38705100 | Hepatic radioembolization complicated by fulminant hepatic failure |
| Q37155002 | Hepatic radiofrequency ablation using multiple probes: ex vivo and in vivo comparative studies of monopolar versus multipolar modes |
| Q28072065 | Hepatocellular adenoma: when and how to treat? Update of current evidence |
| Q53471378 | Histological, CT, and intraoperative ultrasound appearance of hepatic tumors previously treated by laparoscopic radiofrequency ablation. |
| Q30541590 | Image guided tumour ablation |
| Q26738434 | Image-guided high-dose-rate brachytherapy of malignancies in various inner organs - technique, indications, and perspectives |
| Q51042365 | Image-guided multipolar radiofrequency ablation of liver tumours: initial clinical results. |
| Q42145291 | Image-guided percutaneous ablation of pulmonary tumours |
| Q34390851 | Image-guided radiofrequency tumor ablation: challenges and opportunities--part II. |
| Q31161842 | Image-guided tumor ablation: standardization of terminology and reporting criteria |
| Q86095472 | Image-guided tumor ablation: standardization of terminology and reporting criteria--a 10-year update |
| Q36522761 | Imaging Features of Radiofrequency Ablation with Heat-Deployed Liposomal Doxorubicin in Hepatic Tumors |
| Q37522219 | Impact of treatment modality and number of lesions on recurrence and survival outcomes after treatment of colorectal cancer liver metastases |
| Q74465406 | Improved coagulation with saline solution pretreatment during radiofrequency tumor ablation in a canine model |
| Q30422156 | In vivo thermal ablation monitoring using ultrasound echo decorrelation imaging |
| Q43565834 | Incidence and treatment of local site recurrences following RFA of colorectal liver metastases |
| Q34614802 | Incorporation of preprocedural PET into CT-guided radiofrequency ablation of hepatic metastases: a nonrigid image registration validation study |
| Q28550019 | Increased Duration of Heating Boosts Local Drug Deposition during Radiofrequency Ablation in Combination with Thermally Sensitive Liposomes (ThermoDox) in a Porcine Model |
| Q95642320 | Indocyanine Green Clearance Test for the Preoperative Assessment of Chemotherapy-Related Hepatic Injury in Patients with Colorectal Liver Metastasis |
| Q46118659 | Influence of Large Peritumoral Vessels on Outcome of Radiofrequency Ablation of Liver Tumors |
| Q33587685 | Interventional procedures for hepatic metastases |
| Q31030760 | Interventional therapies of unresectable liver metastases |
| Q35993456 | Intra-Tissue Pressure Measurement in Ex Vivo Liver Undergoing Laser Ablation with Fiber-Optic Fabry-Perot Probe. |
| Q38037067 | Intra-arterial hepatic chemotherapy for unresectable colorectal liver metastases: a review of medical devices complications in 3172 patients |
| Q80081239 | Intraoperative magnetic resonance imaging for ablation of hepatic tumors |
| Q35122998 | Intraoperative ultrasonography in liver cancer. |
| Q26825607 | Intraoperative ultrasound in patients with hepatocellular carcinoma: from daily practice to future trends |
| Q36772465 | Isolated hepatic perfusion with 200 mg melphalan for advanced noncolorectal liver metastases |
| Q34128998 | Laser ablation. Do we still need it? |
| Q31083400 | Laser-induced thermotherapy of lung metastases and primary lung tumors |
| Q33193082 | Liver Metastases: Neoadjuvant Downsizing with Transarterial Chemoembolization before Laser-Induced Thermotherapy |
| Q37530649 | Liver ablation techniques: a review. |
| Q35875398 | Liver directed therapies for colorectal cancer. |
| Q47371846 | Liver resection for colorectal metastases: the third hepatectomy |
| Q38256165 | Liver-directed therapies in metastatic colorectal cancer |
| Q90079813 | Local Treatment of Breast Cancer Liver Metastasis |
| Q58755250 | Local ablation or radioembolization of colorectal cancer metastases: comorbidities or older age do not affect overall survival |
| Q36205766 | Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors |
| Q37995052 | Long-term outcome of radiofrequency thermal ablation (RFA) of liver metastases from colorectal cancer (CRC): size as the leading prognostic factor for survival |
| Q37690596 | Long-term outcomes following hepatic resection and radiofrequency ablation of colorectal liver metastases |
| Q36324566 | Long-term results of radiofrequency ablation for unresectable colorectal liver metastases: a potentially curative intervention. |
| Q83971020 | MR-guided radiofrequency ablation using a wide-bore 1.5-T MR system: clinical results of 213 treated liver lesions |
| Q53555220 | Magnetic resonance imaging after radiofrequency ablation in a rodent model of liver tumor: tissue characterization using a novel necrosis-avid contrast agent. |
| Q35029056 | Management of oligometastatic rectal cancer: is liver first? |
| Q36392298 | Metastatic Liver Disease: Indications for Locoregional Therapy and Supporting Data |
| Q36259592 | Microwave Ablation With a Triaxial Antenna: Results in ex vivo Bovine Liver |
| Q41917743 | Microwave ablation in a hepatic porcine model: correlation of CT and histopathologic findings |
| Q81583016 | Microwave ablation of hepatic tumors using dual-loop probes: results of a phase I clinical trial |
| Q53100106 | Microwave ablation of liver metastases to overcome the limitations of radiofrequency ablation. |
| Q53302285 | Microwave ablation therapy for treating primary and secondary lung tumours: technical note. |
| Q51457901 | Microwave thermal ablation for hepatocarcinoma: six liver transplantation cases. |
| Q37982074 | Minimally invasive evaluation and treatment of colorectal liver metastases |
| Q36825521 | Minimally invasive treatment for liver and lung metastases in colorectal cancer |
| Q35737357 | Modern hepatic imaging |
| Q79267571 | Multiple Probe Radiofrequency Ablation: Pilot Study in an Animal Model |
| Q38398883 | Non-operative therapies for colorectal liver metastases |
| Q39957161 | Noninvasive radiofrequency ablation of cancer targeted by gold nanoparticles |
| Q33215701 | Nonoperative ablation for liver metastases. Possibilities and limitations as a curative treatment |
| Q37083651 | Novel approaches to treatment of hepatocellular carcinoma and hepatic metastases using thermal ablation and thermosensitive liposomes. |
| Q33186272 | One or two-stage hepatectomy combined with portal vein embolization for initially nonresectable colorectal liver metastases |
| Q52913023 | Open surgical is superior to percutaneous access for radiofrequency ablation of hepatic metastases. |
| Q26799963 | Optical Fibre Pressure Sensors in Medical Applications |
| Q35805877 | Optimal management of colorectal liver metastases in older patients: a decision analysis |
| Q37231961 | Optimization of wet radiofrequency ablation using a perfused-cooled electrode: a comparative study in ex vivo bovine livers |
| Q47263279 | Pathomorphologic evaluation of pulmonary radiofrequency ablation: proof of cell death is characterized by DNA fragmentation and apoptotic bodies |
| Q47093792 | Percutaneous Image-Guided Cryoablation of Hepatic Tumors: Single-Center Experience With Intermediate to Long-Term Outcomes |
| Q34253356 | Percutaneous ablation of hepatic tumors |
| Q51296233 | Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection: the "test-of-time approach". |
| Q34563371 | Percutaneous radiofrequency thermal ablation of primary and metastatic hepatic tumors: current concepts and review of the literature |
| Q82448127 | Percutaneous stereotactic radiofrequency ablation of colorectal liver metastases |
| Q53654789 | Percutaneous treatment of liver tumors with an adapted probe for cooled-tip, impedance-controlled radio-frequency ablation under open-magnet MR guidance: initial results |
| Q82288170 | Phase I Dose-Escalation Study of Stereotactic Body Radiotherapy in Patients With Hepatic Metastases |
| Q35690829 | Phase I study of heat-deployed liposomal doxorubicin during radiofrequency ablation for hepatic malignancies |
| Q79196755 | Prognostic Factors for Percutaneous Microwave Coagulation Therapy of Hepatic Metastases |
| Q42922856 | Quality improvement guidelines for radiofrequency ablation of liver tumours |
| Q83139377 | Quantitative magnetic resonance temperature mapping for real-time monitoring of radiofrequency ablation of the liver: an ex vivo study |
| Q48820048 | Radio-frequency ablation of colorectal liver metastases in 167 patients |
| Q37326857 | Radioembolization as a Salvage Therapy for Heavily Pretreated Patients With Colorectal Cancer Liver Metastases: Factors That Affect Outcomes |
| Q43148135 | Radiofrequency Ablation for Colon and Rectal Carcinoma Liver Metastases: What's Missing? |
| Q43457482 | Radiofrequency ablation (RFA) of lung metastases from colorectal cancer (CRC)-one-year follow-up |
| Q34563919 | Radiofrequency ablation as a treatment strategy for liver metastases from breast cancer |
| Q37328301 | Radiofrequency ablation combined with KS-IL2 immunocytokine (EMD 273066) results in an enhanced antitumor effect against murine colon adenocarcinoma |
| Q84290738 | Radiofrequency ablation for colorectal liver metastases: prognostic factors in non-surgical candidates |
| Q42281450 | Radiofrequency ablation for hepatic metastasis from gastric adenocarcinoma |
| Q33791372 | Radiofrequency ablation for metastatic hepatic tumor in colorectal carcinoma |
| Q38022509 | Radiofrequency ablation for single lung tumours not suitable for surgery: seven years' experience |
| Q35201716 | Radiofrequency ablation for treating liver metastases from a non-colorectal origin |
| Q36537526 | Radiofrequency ablation in patients with primary and secondary hepatic malignancies. |
| Q36217056 | Radiofrequency ablation induces dedifferentiation of hepatocellular carcinoma |
| Q35895377 | Radiofrequency ablation of cancer |
| Q84567554 | Radiofrequency ablation of hepatic tumours: effect of post-ablation margin on local tumour progression |
| Q33200137 | Radiofrequency ablation of liver metastases |
| Q37867949 | Radiofrequency ablation resulting in left lobe hypertrophy and improved resectability |
| Q57466510 | Radiofrequency ablation versus resection for technically resectable colorectal liver metastasis: a propensity score analysis |
| Q35465647 | Radiofrequency ablation vs hepatic resection for solitary colorectal liver metastasis: a meta-analysis |
| Q59125982 | Radiofrequency ablation with systemic chemotherapy in the treatment of colorectal cancer liver metastasis: a 10-year single-center study |
| Q55446762 | Radiofrequency and Microwave Ablation Compared to Systemic Chemotherapy and to Partial Hepatectomy in the Treatment of Colorectal Liver Metastases: A Systematic Review and Meta-Analysis. |
| Q48712109 | Radiofrequency induced thermotherapy: an alternative palliative treatment modality in head and neck cancer |
| Q81491443 | Radiofrequency thermal ablation of liver tumors |
| Q44235242 | Radiofrequency thermal ablation with expandable needle of focal liver malignancies: complication report |
| Q83129757 | Radiofrequency-ablation of unresectable primary and secondary liver tumors: results in 88 patients |
| Q53642071 | Radiologic Appearance and Complications of Percutaneous Computed Tomography???Guided Radiofrequency-Ablated Pulmonary Metastases from Colorectal Carcinoma |
| Q47414466 | Radiological estimation of size in colorectal liver metastases: is it reliable? Comparison with post-resectional measurements. |
| Q57823584 | Rates and Patterns of Recurrence for Percutaneous Radiofrequency Ablation and Open Wedge Resection for Solitary Colorectal Liver Metastasis |
| Q51618139 | Real-time spectroscopic assessment of thermal damage: implications for radiofrequency ablation. |
| Q55349038 | Recent Advances in the Image-Guided Tumor Ablation of Liver Malignancies: Radiofrequency Ablation with Multiple Electrodes, Real-Time Multimodality Fusion Imaging, and New Energy Sources. |
| Q49186620 | Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases |
| Q37577597 | Repeat liver resection for recurrent colorectal metastases: a single-centre, 13-year experience. |
| Q34180997 | Repeated transarterial chemoembolisation using different chemotherapeutic drug combinations followed by MR-guided laser-induced thermotherapy in patients with liver metastases of colorectal carcinoma |
| Q36563116 | Role of contrast enhanced ultrasound in radiofrequency ablation of metastatic liver carcinoma |
| Q30501440 | Role of contrast-enhanced color Doppler ultrasonography and dynamic flow in the evaluation of hepatic tumors treated with radiofrequency. |
| Q30455429 | Role of contrast-enhanced ultrasonography in percutaneous radiofrequency ablation of liver metastases and efficacy evaluation |
| Q36496678 | Scattered and rapid intrahepatic recurrences after radio frequency ablation for hepatocellular carcinoma |
| Q33593108 | Significance of an increase in the Child-Pugh score after radiotherapy in patients with unresectable hepatocellular carcinoma |
| Q37048588 | Single-dose radiosurgical treatment for hepatic metastases--therapeutic outcome of 138 treated lesions from a single institution |
| Q90478112 | Stereotactic body radiation therapy and radiofrequency ablation for the treatment of liver metastases: How and when? |
| Q38677020 | Stereotactic body radiation therapy in hepatocellular carcinoma: Optimal treatment strategies based on liver segmentation and functional hepatic reserve |
| Q46159777 | Stereotactic body radiotherapy for colorectal liver metastases: a pooled analysis |
| Q50225656 | Stereotactic/hypofractionated body radiation therapy as an effective treatment for lymph node metastases from colorectal cancer: an institutional retrospective analysis. |
| Q35800826 | Structural parameters governing activity of Pluronic triblock copolymers in hyperthermia cancer therapy |
| Q42413389 | Surgical and Pathological Changes after Radiofrequency Ablation of Thyroid Nodules. |
| Q42950084 | Surgical management of colorectal liver metastases |
| Q37727030 | Synergy in cancer treatment between liposomal chemotherapeutics and thermal ablation |
| Q37496689 | Techniques of interventional tumor therapy |
| Q33788183 | Temperature sensitive liposomes combined with thermal ablation: Effects of duration and timing of heating in mathematical models and in vivo |
| Q37878852 | The role of local therapy in the management of lung and liver oligometastases. |
| Q57002477 | The role of lymphadenectomy for liver tumors: further considerations on the appropriateness of treatment strategy |
| Q36116078 | The use of radiofrequency in cancer |
| Q38726773 | Thermal Ablation in the Management of Colorectal Cancer Patients with Oligometastatic Liver Disease |
| Q33511100 | Thermal ablation a comparison of thermal dose required for radiofrequency-, microwave-, and laser-induced coagulation in an ex vivo bovine liver model |
| Q34147203 | Thermal ablation of unresectable liver tumors: factors associated with partial ablation and the impact on long-term survival. |
| Q30857854 | Thermal ablation therapy for hepatocellular carcinoma |
| Q42605002 | Time and dose dependence of pluronic bioactivity in hyperthermia-induced tumor cell death |
| Q35059584 | Treatment efficacy of radiofrequency ablation of 338 patients with hepatic malignant tumor and the relevant complications |
| Q45260050 | Treatment for liver metastases from colorectal cancer |
| Q34014071 | Tumour ablation: current role in the liver, kidney, lung and bone |
| Q36309287 | Ultrasonography guided percutaneous radiofrequency ablation for hepatic cavernous hemangioma |
| Q37392026 | Update and review of the multidisciplinary management of stage IV colorectal cancer with liver metastases |
| Q34129018 | Update on interstitial brachytherapy |
| Q47161687 | Updates on the Management of Advanced, Metastatic, and Radioiodine Refractory Differentiated Thyroid Cancer |
| Q39256308 | Value of percutaneous radiofrequency ablation with or without percutaneous vertebroplasty for pain relief and functional recovery in painful bone metastases. |
| Q35569398 | Viable tumor tissue adherent to needle applicators after local ablation: a risk factor for local tumor progression |
| Q79946062 | [Combined therapies including interventional radiology] |
| Q79708863 | [Metastases of colorectal carcinoma] |
| Q79424363 | [Regional therapy of liver tumors] |
Search more.